Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALKYRIE: Rivaroxaban vs VKA in Hemodialysis
NCT02610933Phase 4Completed
- Sponsor
- OLV Hospital
- Start
- Nov 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban, menaquinone in Vascular calcification, Atrial fibrillation (AFib), sponsored by OLV Hospital. Started Nov 2015; status: completed.
02
Drugs
rivaroxabanmenaquinone
03
Conditions
Vascular calcificationAtrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02610933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02610933.